# A Study to Evaluate the Intramuscular Administration of Scopolamine

> **NCT04314713** · PHASE1 · TERMINATED · sponsor: **Battelle Memorial Institute** · enrollment: 32 (actual)

## Conditions studied

- Medical Countermeasures
- Organophosphate Poisoning

## Interventions

- **DRUG:** Scopolamine Hydrobromide Trihydrate

## Key facts

- **NCT ID:** NCT04314713
- **Lead sponsor:** Battelle Memorial Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-02
- **Primary completion:** 2021-04-06
- **Final completion:** 2021-05-06
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** DSMB decision due to adverse events
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04314713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04314713, "A Study to Evaluate the Intramuscular Administration of Scopolamine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04314713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*